Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.520
-0.150 (-3.21%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Cryo-Cell International Market Cap
Cryo-Cell International has a market cap or net worth of $36.42 million as of September 12, 2025. Its market cap has decreased by -31.03% in one year.
Market Cap
36.42M
Enterprise Value
47.75M
1-Year Change
-31.03%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since December 1, 1998, Cryo-Cell International's market cap has increased from $21.70M to $36.42M, an increase of 67.83%. That is a compound annual growth rate of 1.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 36.40M | -39.03% |
Dec 31, 2024 | 59.70M | 25.42% |
Dec 29, 2023 | 47.60M | 32.22% |
Dec 30, 2022 | 36.00M | -63.60% |
Dec 31, 2021 | 98.90M | 70.22% |
Dec 31, 2020 | 58.10M | 4.50% |
Dec 31, 2019 | 55.60M | -4.96% |
Dec 31, 2018 | 58.50M | -14.85% |
Dec 29, 2017 | 68.70M | 121.61% |
Dec 30, 2016 | 31.00M | 6.90% |
Dec 31, 2015 | 29.00M | 21.34% |
Dec 31, 2014 | 23.90M | 20.10% |
Dec 31, 2013 | 19.90M | -14.96% |
Dec 31, 2012 | 23.40M | -0.43% |
Dec 30, 2011 | 23.50M | -16.67% |
Dec 31, 2010 | 28.20M | 34.93% |
Dec 31, 2009 | 20.90M | 326.53% |
Dec 31, 2008 | 4.90M | -46.74% |
Dec 31, 2007 | 9.20M | -65.28% |
Dec 29, 2006 | 26.50M | -32.91% |
Dec 30, 2005 | 39.50M | -19.22% |
Dec 31, 2004 | 48.90M | 431.52% |
Dec 31, 2003 | 9.20M | -50.27% |
Dec 31, 2002 | 18.50M | -65.80% |
Dec 31, 2001 | 54.10M | 132.19% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 678.14B |
Johnson & Johnson | 428.83B |
AbbVie | 385.71B |
UnitedHealth Group | 319.26B |
AstraZeneca | 247.84B |
Novo Nordisk | 242.99B |
Novartis AG | 240.09B |
Abbott Laboratories | 232.75B |